Nifedipine and captopril exert divergent effects on heart rate variability in patients with acute episodes of hypertension

Journal of Human Hypertension

Volumn 10, Issue 5, 1996, Pages 327-332

  Wolk, R ^a,b   Kulakowski, P ^a   Ceremuzynski, L ^a  

^a GROCHOWSKI HOSPITAL   (Poland)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Captopril; Heart rate variability; Nifedipine

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; DRUG CHOICE; FEMALE; HEART CYCLE; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; MALE; RANDOMIZED CONTROLLED TRIAL; SUBLINGUAL DRUG ADMINISTRATION; SYSTOLIC BLOOD PRESSURE; VARIANCE;

ACUTE DISEASE; ADMINISTRATION, SUBLINGUAL; ADULT; AGED; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; EMERGENCY MEDICAL SERVICES; FEMALE; HEART RATE; HOSPITALIZATION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE;

EID: 0029933982     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kleiger RE, Miller JP, Bigger JT, Moss AJ. Multicenter post-infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256-262.
2. McKenna WJ, Camm AJ. Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. Circulation 1989; 80: 1489-1492.
3. Levy D et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
4. Hayano J et al. Decreased magnitude of heart rate spectral components in coronary artery disease. Circulation 1990; 81: 1217-1224.
5. McCabe PM, Yongue BG, Ackles PK, Porges SW. Changes in heart period, heart-period variability and a spectral analysis estimate of respiratory sinus arrhythmia in response to pharmacological manipulations of the baroreceptor reflex in cats. Psychophysiology 1985; 22: 195-203.
6. Eberg TJ. Captopril potentiates chronotropic baroreflex responses to carotid stimuli in humans. Hypertension 1985; 7: 602-606.
7. Stein PK, Bosner MS, Kleiger RE, Conger BM. Heart rate variability: a measure of cardiac autonomic tone. Am Heart J 1994; 127: 1376-1381.
8. Fei L, Malik M. Heart rate variability - methodology and physiological basis. In: Aubert AE, Ector H, Stroobandt R (eds). Cardiac pacing and electrophysiology. Kluwer Academic Publishers: London, 1994, pp 49-62.
9. Freed LA et al. Reproducibility of power spectral measures of heart rate variability obtained from short-term sampling periods. Am J Cardiol 1994; 74: 972-973.
10. De Boer RW, Karemaker JM, Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat to beat model. Am J Physiol 1987; 253: H680-H689.
11. Bernardi L et al. Evidence that low frequency variability of the RR interval power spectrum analysis in humans is generated by the arterial baroreflex. Presented at the XXXII Congress International Union of Physiological Sciences, 1-6 August, 1993, Glasgow, Scotland.
12. Cerutti C, Barres C, Paultre C. Baroreflex modulation of blood pressure and heart rate variabilities in rats: assessment by spectral analysis. Am J Physiol 1994; 266: H1993-H2000.
13. Spyer KM. Central nervous mechanisms contributing to cardiovascular control. J Physiol 1994; 474: 1-19.
14. Johnston CI, Ciappison BH, Anderson WP, Yasujima M. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels. Am J Cardiol 1982; 49: 1301-1404.
15. Zimmerman BG, Sybertz EJ, Wong PC. Interaction between sympathetic and renin-angiotensin system. J Hypertens 1984; 2: 581-587.
16. Foucart S, de Champlain J, Nadeau R. Modulation by β-adrenoceptors and angiotensin II receptors of splanchnic nerve evoked catecholamine release from adrenal medulla. Can J Physiol Pharmacol 1991; 69: 1-7.
17. Aldred GP et al. Distribution of angiotensin II receptor subtypes in the rabbit brain. Regul Pept 1993; 44: 119-130.
18. Sasaki S, Dampney RA. Tonic cardiovascular effects of angiotensin II in the ventrolateral medulla. Hypertension 1990; 15: 274-283.
19. Muratani H, Ferrario CM, Averill DB. Ventrolateral medulla in spontaneously hypertensive rats: role of angiotensin II. Am J Physiol 1993; 264: R388-R395.
20. Ferrario CM. The renin-angiotensin system; importance in physiology and pathology. J Cardiovasc Pharmacol 1990; 15 (Suppl 3): S1-S5.
21. Lombardi F et al. Restraining effect of captopril on cardiovascular sympathetic efferent neural activity. J Auton Nerv Syst 1989; 7 (Suppl 7): S110-S116.
22. Pagani M et al. Effects of chronic cilazapril treatment on cardiovascular control: a spectral analytical approach. J Cardiovasc Pharmacol 1992; 19 (Suppl 6): S110-S116.
23. Lumbers ER, McCloskey DI, Potter EK. Inhibition by angiotensin II of baroreceptor-evoked activity i cardiac vagal efferent nerves in the dog. J Physiol 1979; 294: 69-80.
24. Lee WB, Ismay MJ, Lumbers ER. Mechanisms by which angiotensin II affects the heart rate of the conscious sheep. Circ Res 1980; 47: 286-92.
25. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and cardiac arrhythmias. In: Zipes DP, Jalife J (eds). Cardiac electrophysiology: from cell to bedside. WB Saunders Co: Philadelphia, USA, 1990, pp 330-343.
26. Vanoli E et al. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 1991; 68: 1471-1481.
27. Hohnloser SH et al. Reflex vs tonic vagal activity as a prognostic parameter in patients with sustained ventricular tachycardia or ventricular fibrillation. Circulation 1994; 89: 1068-1073.
28. Gribbin B, Pickering TG, Sleight P, Peto R. Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 1971; 29: 424-431.
29. Binkley PF et al. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. Am J Cardiol 1993; 21: 655-661.
30. Huikuri HV et al. Frequency domain measures of heart rate variability before the onset of nonsustained and sustained ventricular tachycardia in patients with coronary artery disease. Circulation 1993; 87: 1220-1228.
31. Fei L et al. Change of autonomic influence on the heart immediately before the onset of spontaneous idiopathic ventricular tachycardia. J Am Coll Cardiol 1994; 24: 1515-1522.
32. De Champlain J et al. Effects of trandolapril on the sympathetic tone and reactivity in systemic hypertension. Am J Cardiol 1994; 73: 18C-25C.
33. Akselrod S et al. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981; 213: 220-223.